Hepatocellular carcinoma (HCC) or hepatoma is malignant cancer that starts from the main
liver cells. Although various classical methods have been used for patients with HCC …

The incidence of hepatocellular carcinoma (HCC) and HCC-related deaths has increased
over the last few decades. There are several risk factors of HCC such as viral hepatitis (B …

Overdiagnosis refers to detection of disease that would not otherwise become clinically
apparent during a patient's lifetime. Overdiagnosis is common and has been reported for …

Volatile organic compounds (VOCs) profile for diagnosis and monitoring therapeutic
response of hepatocellular carcinoma (HCC) has not been well studied. We determined …

Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver with high
morbidity and mortality rates worldwide. Since 1963, when alpha-fetoprotein (AFP) was …

Hepatocellular carcinoma (HCC) is an aggressive tumor, and even with the breakthrough in
preventive strategies, and new diagnostic and treatment modalities, incidence and fatality …

The annual incidence of hepatocellular carcinoma (HCC) continues to rise. Over the last two
decades, liver transplantation (LT) has become the preferable treatment of HCC, when …

Simple Summary Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease, and it is an increasing factor in the cause of hepatocellular carcinoma (HCC). The …

BACKGROUND The clinical management and prognosis differ between benign and
malignant solid focal liver lesions (FLLs), as well as among different pathological types of …

Proteomics continues to forge significant strides in the discovery of essential biological
processes, uncovering valuable information on the identity, global protein abundance …